(+)-trans-Cannabidiol is a CB2 receptor agonist
Pedro Bans Burtchaell, Marina Santiago, Chenxi Wang, Mehdi Hagdoost, Evie J. M. Clay, Dani Mohnot, Mark A. Connor
This study investigates the pharmacological activity of (+)-trans-CBD at CB1 and CB2 receptors, finding it acts as a CB2 agonist with higher affinity than (-)-CBD.
bioRxiv · May 26, 2026 · PreprintPharmacology & Toxicology